(Q80982723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Hip fractures in users of first- vs. second-generation bisphosphonates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

M Mamdani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

A Kopp

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

G Hawker

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1595-1600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767369%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-007-0446-5

4 January 2020

exact match

0 references

cites work

Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.

1 reference

12 December 2020

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

12 December 2020

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

1 reference

12 December 2020

Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

1 reference

12 December 2020

Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.

1 reference

12 December 2020

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

12 December 2020

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data

1 reference

12 December 2020

Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis

1 reference

12 December 2020

Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women

1 reference

12 December 2020

The worldwide problem of osteoporosis: insights afforded by epidemiology

1 reference

12 December 2020